3 Aug 17

The four treatment options studied had been continuing donepezil 10 mg/day time in 73 individuals, discontinuing the medication in 73, stopping donepezil and starting memantine 20 mg/day in 76 and both continuing donepezil and beginning memantine in 73 individuals. The introduction of memantine, which is accepted for moderate-to-severe AD, did not have a significant effect on nursing home entrance, either with or without donepezil, the researchers take note. Licensed from medwireNews with permission from Springer Health care Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment..